Analyst	Recommendation	Action	Price target	Projected	Date
Thomas O'Malley Barclays	Sell	Downgraded	$40.00	-17.7%	07/20/2026
Brian Chin Stifel Nicolaus	Buy	Reiterated	$75.00	+54.3%	07/08/2026
Nick Doyle Needham	Buy	Reiterated	$80.00	+64.5%	07/08/2026
Matthew Calitri Needham	Buy	Reiterated	$80.00	+64.5%	07/08/2026
Rustam Kanga Citizens JMP	Buy	Maintained	$85.00	+74.8%	07/08/2026
Kevin Cassidy Rosenblatt Securities	Buy	Reiterated	$75.00	+54.3%	07/08/2026
Katherine Murphy Goldman Sachs	Buy	Maintained	$25.00	-48.6%	04/13/2026
Unknown Analyst Goldman Sachs	Buy	Maintained	$25.00	-48.6%	01/13/2026

All values in USD	Aug 2025	Nov 2025	Feb 2026	May 2026
Revenue	337.92M	343.07M	343.00M	478.71M
Cost of goods sold	240.85M	247.44M	249.30M	345.50M
Cost of revenue	240.85M	247.44M	249.30M	345.50M
Research and development expenses	19.86M	18.69M	18.98M	21.98M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	56.77M	53.09M	47.99M	59.40M
Operating expense	76.63M	71.78M	66.96M	81.39M
Total operating expenses	317.48M	319.23M	316.26M	426.89M
Operating income	20.44M	23.84M	26.74M	51.83M
Other non operating income	90.00K	-482.00K	-68.00K	673.00K
EBT including unusual items	9.35M	7.86M	52.95M	53.70M
EBT excluding unusual items	20.29M	22.10M	26.96M	50.77M
Income tax expense	-1.20M	1.80M	14.41M	7.52M
Effective tax rate	-12.79%	22.96%	27.21%	13.99%
Other operating expenses	-	-	-	-
Net income	9.43M	5.27M	37.45M	44.69M
Net profit margin	2.79%	1.54%	10.92%	9.34%
Earnings per share	0.43	0.49	0.52	0.84
Interest and investment income	-	-	-	-
Interest expense	-153.00K	-47.00K	-721.00K	-650.00K
Net interest expenses	-153.00K	-47.00K	-721.00K	-650.00K
Depreciation and amortization charges	-	-	-	-
EBITDA	33.64M	36.66M	39.49M	64.13M
Gain or loss from assets sale	-	-	-	-

Ask anything